Jeevan Scientific Technology Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating on Jeevan Scientific Technology Ltd indicates a cautious stance for investors considering this stock. This rating suggests that the stock may underperform relative to the broader market or its sector peers in the near to medium term. It is important to understand that this recommendation is based on a comprehensive evaluation of multiple parameters, including the company’s quality, valuation, financial trend, and technical indicators as they stand today.

Quality Assessment: Below Average Fundamentals

As of 25 December 2025, Jeevan Scientific Technology Ltd exhibits below average quality metrics. The company’s long-term fundamental strength remains weak, with a concerning compound annual growth rate (CAGR) of operating profits at -204.41% over the past five years. This negative growth trajectory highlights persistent challenges in generating sustainable earnings growth.

Additionally, the average Return on Equity (ROE) stands at 9.56%, which is modest and indicates limited profitability relative to shareholders’ equity. The latest quarterly results further underscore these concerns, with a net loss (PAT) of ₹0.09 crore, reflecting a sharp decline of 137.5% compared to previous quarters. Such figures suggest that the company is struggling to convert its operations into consistent profits, a key factor weighing on its quality grade.

Valuation: Risky Positioning

The valuation of Jeevan Scientific Technology Ltd is currently classified as risky. Despite the stock’s microcap status, it is trading at levels that do not align favourably with its historical valuation benchmarks. The company’s negative operating profits contribute to this risk profile, signalling that investors are paying a premium for a stock with uncertain earnings prospects.

Over the past year, the stock has delivered a return of 23.66%, which might appear attractive at first glance. However, this price appreciation contrasts sharply with a 450% decline in profits over the same period, indicating a disconnect between market price and underlying financial health. Such disparity often signals speculative interest rather than fundamental strength, warranting caution from investors.

Financial Trend: Flat and Challenging

The financial trend for Jeevan Scientific Technology Ltd remains flat, reflecting stagnation rather than growth. The company’s recent half-year inventory turnover ratio is 18.86 times, which is relatively low and may indicate inefficiencies in managing stock levels. Furthermore, the dividend payout ratio is currently at 0.00%, signalling that the company is not returning cash to shareholders through dividends, likely due to its constrained profitability.

These factors combined suggest that the company is not demonstrating the financial momentum investors typically seek for a positive outlook. The flat financial grade reinforces the notion that the stock’s fundamentals do not support a bullish stance at this time.

Technical Outlook: Mildly Bullish but Cautious

From a technical perspective, the stock shows a mildly bullish trend. Recent price movements include a 2.16% gain on the latest trading day, with a one-month return of 3.28% and a three-month surge of 75.13%. The six-month return also stands strong at 62.42%, and the year-to-date return is 25.09%. These figures indicate some positive momentum in the stock price, which may attract short-term traders.

However, technical strength alone does not offset the underlying fundamental and valuation concerns. Investors should weigh these technical signals carefully against the broader financial picture before making investment decisions.

What This Rating Means for Investors

The 'Sell' rating on Jeevan Scientific Technology Ltd serves as a cautionary signal for investors. It suggests that the stock currently carries elevated risks due to weak fundamentals, risky valuation, and flat financial trends, despite some technical optimism. Investors looking for stable growth or reliable income may find this stock less appealing under current conditions.

For those considering exposure to this stock, it is essential to monitor ongoing financial results and market developments closely. The rating reflects a comprehensive assessment that balances the company’s challenges with its recent price performance, providing a nuanced view of its investment potential.

Summary

In summary, Jeevan Scientific Technology Ltd’s current 'Sell' rating by MarketsMOJO, last updated on 13 Nov 2025, reflects a comprehensive evaluation of its present-day financial and market position as of 25 December 2025. The company faces significant challenges in profitability and valuation, despite some positive technical momentum. Investors should approach this stock with caution, considering the risks highlighted by the below average quality, risky valuation, flat financial trend, and only mildly bullish technical outlook.

Careful analysis and ongoing monitoring are advised for those holding or contemplating investment in this microcap healthcare services company.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today